Diabetes Insipidus for USMLE Step 1

Diabetes Insipidus (DI) for the USMLE Step 1 Exam
  • Pathophysiology
    • Impaired ADH Activity: Diabetes insipidus (DI) is characterized by a deficiency of antidiuretic hormone (ADH) or renal resistance to its effects. This impairs water reabsorption in the renal collecting ducts, leading to excessive water loss.
    • Polyuria and Polydipsia: The loss of free water results in large volumes of dilute urine (polyuria), leading to dehydration and compensatory thirst (polydipsia).
  • Types of DI
    • Central DI: Results from inadequate secretion of ADH.
    • Causes:
    • Idiopathic: The most common cause, likely related to autoimmune destruction of ADH-secreting neurons.
    • Trauma or Surgery: Head trauma or neurosurgery can damage the hypothalamus or pituitary gland.
    • Tumors: Pituitary adenomas, craniopharyngiomas, or metastases.
    • Infiltrative Diseases: Conditions like sarcoidosis, tuberculosis, or histiocytosis affecting the hypothalamic-pituitary axis.
    • Nephrogenic DI: Due to renal resistance to ADH, even though ADH secretion is normal or elevated.
    • Causes:
    • Genetic Mutations: Mutations in the V2 receptor or aquaporin-2 water channels.
    • Medications: Lithium is a major cause of drug-induced nephrogenic DI.
    • Electrolyte Imbalances: Hypercalcemia and hypokalemia can impair the kidney's ability to respond to ADH.
    • Chronic Kidney Disease: Reduced ability to concentrate urine.
  • Clinical Features
    • Polyuria: Urine output exceeding 3 liters/day, sometimes reaching 20 liters/day in severe cases.
    • Polydipsia: Excessive thirst as a compensatory mechanism to prevent dehydration.
    • Nocturia: Frequent urination at night.
    • Dehydration: If water intake is insufficient, symptoms of dehydration, such as dry mucous membranes, hypotension, and tachycardia, may develop.
    • Hypernatremia: Can occur if fluid intake is inadequate, leading to high serum sodium levels.
  • Diagnosis
    • Clinical Suspicion: Polyuria and polydipsia should raise suspicion for DI.
    • Water Deprivation Test:
    • Purpose: Differentiates central and nephrogenic DI from primary polydipsia.
    • Procedure: After water deprivation, the patient’s urine osmolality is measured, followed by desmopressin administration.
    • Central DI: Low urine osmolality that improves with desmopressin.
    • Nephrogenic DI: Urine remains dilute after desmopressin.
    • Primary Polydipsia: Urine osmolality increases after water deprivation due to normal ADH function.
    • Urine and Plasma Osmolality:
    • Serum Osmolality: Increased (>295 mOsm/kg) due to water loss.
    • Urine Osmolality: Decreased (<300 mOsm/kg) due to inability to concentrate urine.
    • Serum Sodium: Hypernatremia may develop in cases of dehydration.
  • Treatment
    • Central DI:
    • Desmopressin (DDAVP): A synthetic ADH analog used to replace the missing hormone. It can be administered intranasally, orally, or subcutaneously.
    • Monitoring: Adjust desmopressin dosage to avoid water intoxication (hyponatremia).
    • Treatment of Underlying Cause: Address tumors, trauma, or infiltrative diseases if present.
    • Nephrogenic DI:
    • Discontinue Offending Medications: Stop drugs like lithium that contribute to nephrogenic DI.
    • Thiazide Diuretics: Paradoxically reduce urine output by inducing mild hypovolemia, which enhances proximal sodium and water reabsorption.
    • Low-Sodium Diet: Helps to reduce urine output.
    • Amiloride: Especially useful for lithium-induced nephrogenic DI, as it blocks lithium entry into renal cells.
  • Complications
    • Hypernatremia: If water intake does not compensate for water loss, patients may develop severe hypernatremia, which can cause confusion, seizures, or coma.
    • Dehydration: Significant fluid loss without adequate replacement can result in hypotension, tachycardia, and potentially shock.
Key Points
  • Pathophysiology:
    • Central DI is caused by insufficient ADH production, while nephrogenic DI results from renal resistance to ADH.
    • Both result in polyuria, polydipsia, and inability to concentrate urine.
  • Causes:
    • Central DI causes include head trauma, tumors, surgery, and idiopathic factors.
    • Nephrogenic DI causes include lithium use, genetic mutations, and electrolyte imbalances.
  • Diagnosis:
    • Water deprivation test differentiates central DI from nephrogenic DI and primary polydipsia.
    • Key findings include high serum osmolality and low urine osmolality.
  • Treatment:
    • Central DI is treated with desmopressin.
    • Nephrogenic DI management includes thiazide diuretics, a low-sodium diet, and addressing underlying causes.
  • Complications:
    • Hypernatremia and dehydration are serious risks if DI is not managed properly.